GERON CORP's ticker is GERN and the CUSIP is 374163103. A total of 202 filers reported holding GERON CORP in Q3 2023. The put-call ratio across all filers is 0.78 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,710,460 | -23.0% | 10,712,481 | +16.6% | 6.06% | +2.1% |
| Q2 2023 | $29,504,041 | +61.8% | 9,191,290 | +9.4% | 5.94% | +25.4% |
| Q1 2023 | $18,231,396 | -11.0% | 8,401,565 | -0.8% | 4.74% | -10.9% |
| Q4 2022 | $20,490,094 | +4.0% | 8,466,981 | +0.5% | 5.32% | +13.9% |
| Q3 2022 | $19,709,000 | +50.7% | 8,422,582 | -0.1% | 4.67% | +28.5% |
| Q2 2022 | $13,074,000 | +56.3% | 8,434,991 | +37.2% | 3.63% | +61.9% |
| Q1 2022 | $8,363,000 | +21.9% | 6,149,277 | +9.3% | 2.24% | +79.4% |
| Q4 2021 | $6,861,000 | -12.6% | 5,623,889 | -1.9% | 1.25% | +2.7% |
| Q3 2021 | $7,854,000 | – | 5,732,770 | – | 1.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TCG Crossover Management, LLC | 23,375,839 | $49,556,779 | 7.30% |
| MPM BioImpact LLC | 10,712,481 | $22,710,460 | 6.06% |
| Ally Bridge Group (NY) LLC | 2,221,639 | $4,709,875 | 5.53% |
| Vivo Capital, LLC | 16,524,634 | $35,032,224 | 3.84% |
| NEA Management Company, LLC | 22,776,409 | $48,285,987 | 3.73% |
| Deep Track Capital, LP | 25,700,000 | $54,484,000 | 2.10% |
| RA Capital Management | 46,202,425 | $97,949,141 | 1.93% |
| Velan Capital Investment Management LP | 778,500 | $1,650,420 | 1.33% |
| Opaleye Management Inc. | 1,915,000 | $4,059,800 | 1.32% |
| Nan Fung Group Holdings Ltd | 753,550 | $1,597,526 | 1.29% |